# PRIMA US-Feasibility Study in Atrophic Dry AMD

> **NCT03392324** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Science Corporation** · enrollment: 5 (actual)

## Conditions studied

- Dry Age-related Macular Degeneration

## Interventions

- **DEVICE:** PRIMA

## Key facts

- **NCT ID:** NCT03392324
- **Lead sponsor:** Science Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-26
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03392324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03392324, "PRIMA US-Feasibility Study in Atrophic Dry AMD". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03392324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*